Thus, the present study, that assesses the association between −1377 G/A and −670 A/G polymorphisms in FAS as well as single nucleotide polymorphisms −844 C/T and INV2nt −124 A/G in FASL adds an important information about the role of this death pathway in breast cancer. This evidence concerns the gene FAS and breast carcinoma.